Alkermes and Takeda are developing orexin-related therapies and plan to present detailed data at a meeting on July 21, 2025.
1 report, 1 independent
Updated Jul 21
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Alkermes and Takeda are developing orexin-related therapies and plan to present detailed data at a meeting on July 21, 2025.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
Coverage
Newest first; wire copies grouped- BioPharma DiveAlkermes narcolepsy drug headed for late-stage testing This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter